Yu Xia - Jan 17, 2023 Form 3 Insider Report for Summit Therapeutics Inc. (SMMT)

Role
Director
Signature
/s/ Ankur Dhingra, as Attorney-in-Fact for Yu Xia
Stock symbol
SMMT
Transactions as of
Jan 17, 2023
Transactions value $
$0
Form type
3
Date filed
1/26/2023, 01:48 PM
Next filing
Feb 14, 2024

No securities are beneficially owned.

Remarks:

Exhibit 24 - Power of Attorney